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Phenylalanine meta-Hydroxylase: A Single Residue
Mediates Mechanistic Control of Aromatic Amino Acid
Hydroxylation
Sabine Greschow,[a] Joanna C. Sadler,[a] Peter J. Sharratt,[b] and Rebecca J. M. Goss*[a]
Introduction
Aromatic amino acid hydroxylases represent a small but impor-
tant group of enzymes responsible for a series of metabolically
essential transformations, including the hydroxylation of l-tyro-
sine, l-tryptophan or l-phenylalanine to yield l-DOPA, 5-hy-
droxy-l-tryptophan or l-tyrosine, respectively.[1] These non-
heme-iron-dependent enzymes bind their metal cofactor at
the active site with one glutamate and two histidine residues,
a binding mode that is also found in other non-heme-iron en-
zymes such as the a-ketoglutarate-dependent dioxygenases.[2,3]
A significant difference from other non-heme-iron-dependent
enzymes is the requirement for tetrahydropterin as an addi-
tional cofactor. The mammalian aromatic amino acid hydroxy-
lases have been extensively studied; this revealed a common
catalytic cycle (Scheme 1).[4–6] The cycle starts with the ferrous
iron enzyme complex binding the tetrahydropterin cofactor,
the amino acid substrate and molecular oxygen. The latter
then reacts with the tetrahydropterin to form a m-bridged
pterin–iron intermediate, which has been proposed to be the
precursor of the active ferryl-oxo species. This species serves as
the electrophile for an electrophilic aromatic substitution reac-
tion with the phenylalanine substrate through a cationic inter-
mediate, which then undergoes 1,2-hydride (NIH) shift and tau-
tomerisation to yield the hydroxylated amino acid. The ferrous
state of the iron is re-established, and the product and hydrox-
ypterin (4a-carbinolamine) are released from the enzyme. Addi-
tional enzymes, pterin dehydratase and pterin dehydrogenase,
recycle the pterin co-factor.[4, 7, 8] Whilst aromatic amino acid
hydroxylation is essential in mammalian systems, prokaryotes
synthesise aromatic amino acids according to the Shikimate
pathway and, as such, hydroxylases are less abundant in bacte-
ria.[9] An interesting member of the bacterial hydroxylase
family that has not been found in eukaryotes is phenylalanine
3-hydroxylase (Phe3H), which catalyses the biogenesis of meta-
tyrosine (meta-Tyr) from phenylalanine.[10] meta-Tyr is found in
a small number of bacterial natural products, including the im-
munosuppressant sanglifehrin, thaxtomin (a metabolite associ-
ated with the appearance of potato scab) and the uridyl pep-
tide antibiotics (UPAs) such as the pacidamycins and structural-
ly related napsamycins, mureidomycins and sansanmycins.
Within the UPA family, the presence of meta-Tyr enables the
formation of bicyclic phenylalanine derivatives through a Pictet
Spengler reaction with a small series of aldehydes, thereby
masking the terminal amine, which is known to be critical for
antibiotic activity and plausibly conferring resistance and host
protection.[11,12]
Inactivation of the gene encoding phenylalanine 3-hydroxy-
lase (Phe3H) in Streptomyces coeruleorubidus results in the loss
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of production of meta-Tyr-containing pacidamycins, thus dem-
onstrating the essential nature of the gene for meta-Tyr pro-
duction.[13] meta-Tyr also has a level of herbicidal activity and is
used by certain grasses in allelopathy, where it is thought be
synthesised by an unidentified P450 enzyme.[14,15] In mammals,
meta-Tyr is generated nonenzymatically from phenylalanine
under conditions of oxidative stress.[16,17]
Phe3H from S. coeruleorubidus shares 75–78% amino acid
sequence identity with proteins encoded in the biosynthetic
gene clusters for mureidomycin, napsamycin and sansanmycin
and the cluster for the structurally unrelated sanglifehrin (51%
identity at the protein level). The meta-Tyr moiety in thaxto-
min, on the other hand, is likely to be derived from a cyto-
chrome P450-catalysed tailoring step.[18] To date, none of these
hydroxylases has been studied in detail, and little is known
about their catalytic mechanism.[10] In comparison, the se-
quence identity of phenylalanine 3-hydroxylases to character-
ised bacterial phenylalanine 4-hydroxylases ranges from 24–
28%.
Walsh and co-workers have previously reported kinetic pa-
rameters for Phe3H from S. coeruleorubidus and carried out
preliminary mutational analysis of putative active-site resi-
dues.[10] However, to date it is unknown if Phe3H operates by
a mechanism analogous to that for Phe4H (Scheme 1) or by
another mechanism. We have furthered our understanding of
this intriguing enzyme with additional analysis of its Michaelis–
Menten kinetics and identification of inhibitors, and show its
ability to regiospecifically hydroxylate a series of fluorinated
substrates. These data prompted us to perform a series of iso-
tope labelling and mutational analysis experiments, which re-
vealed that, unlike other characterised amino acid hydroxylas-
es, the electrophilic aromatic substitution may proceed with
enzyme-catalysed deprotonation prior to the tautomerisation
step and does not necessarily involve an NIH shift, with this
mechanistic control being mediated by the T202 residue.
Results and Discussion
Kinetics of Phe3H
The steady-state kinetic parameters for Phe3H with two differ-
ent pterin cofactors were determined (Table 1 and Figure S7 in
the Supporting Information) under optimised assay conditions
(Figure S2). In comparison to the previously reported data,
which were obtained at pH 6, we observed a 30-fold increase
in kcat and twofold increase in KM working at pH 8.
[10] The intri-
cate interplay between the iron, pterin and substrate is high-
lighted by entries 1 and 2, in which the pterin cofactor is
DMPH4 or (:)-6-methyl-5,6,7,8-tetrahydropterin (6MPH4), re-
spectively. The only structural difference between these pterins
is an additional methyl group in DMPH4. Using DMPH4 rather
than 6MPH4 results in an approximately 50% increase in KM for
l-Phe and, conversely, an almost twofold increase in kcat.
Whereas substrate inhibition was observed when 6MPH4 was
used as a cofactor (Table 1, entry 3), it was not observed with
DMPH4. To enable better comparison with literature data,
6MPH4 was selected for further analysis of Phe3H.
[10]
Scheme 1. The established mechanism of tyrosine biogenesis from phenylalanine mediated by a mammalian non-heme-iron hydroxylase and using the co-
factor tetrahydrobiopterin (BH4) to yield the para-hydroxylated product.
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Substrate specificity
To interrogate the substrate scope of Phe3H, a suite of non-
native substrates was screened under the optimised assay con-
ditions. The electron-rich substrate l-Tyr was seen to be a very
poor substrate, with only traces (<1%) of hydroxylated prod-
uct being detected by LC-MS. Similarly, the bulkier substrate
l-Trp was also a poor substrate, giving <1% conversion to
hydroxylated product.
Studies with dl-2-fluorophenylalanine (2F-Phe), dl-3-fluoro-
phenylalanine (3F-Phe) and dl-4-fluorophenylalanine (4F-Phe)
revealed surprising results, with 2F-Phe and 4F-Phe being read-
ily processed to the corresponding meta hydroxylated product.
Akin to the observations with mammalian aromatic amino acid
hydroxylases, Phe3H displayed very tight control of regiochem-
istry. As with l-Trp and l-Tyr, the reaction with 3F-Phe only
revealed products by LC-MS analysis, with traces (<1%) of hy-
droxylated fluorophenylalanine and meta-Tyr being detected
(Scheme 2). The latter compound is produced by dehalogena-
tion, which is frequently observed for aromatic amino hydroxy-
lases.[19–21] In comparison to other hydroxylases, the low extent
of defluorination seen for Phe3H is surprising. For example, rat
TyrOHase converts 4F-Phe to Tyr and 3F-Tyr to DOPA.[6] Similar-
ly, the dehalogenation of 4F-Phe to give tyrosine has also been
reported for rat and sheep liver phenylalanine hydroxylas-
es.[19,20] Further studies revealed 3F-Phe to be a competitive
inhibitor of Phe3H, with a Ki of 0.8 mm (Figure S8). It was
postulated that 3F-Phe might act as a product mimic due to
the isosteric nature of the C@F and C@OH bonds. Furthermore,
oxidation of the tetrahydropterin cofactor in the presence of
only 3F-Phe is the same as background oxidation, as is ob-
served in the absence of any amino acid substrate (Figure S11),
thus indicating that 3F-Phe prevents binding of Phe to the
active site and that it prevents formation of the active ferryl-
oxo species.
Although we observed l-tyrosine to be a poor substrate, the
almost isosteric 4F-Phe proved to be a good substrate with an
almost twofold lower KM than that of l-Phe (Table 1, entry 4
and Figure S7). The rate of the reaction was significantly
slower for the fluorinated phenylalanines compared to non-
fluorinated Phe; it was hypothesised that this is due to the
weakly deactivating character of fluorine substituents in elec-
trophilic aromatic substitution reactions. 2F-Phe was also ac-
cepted as a substrate, albeit less efficiently than the 4F-Phe
analogue (Table 1, entry 5), with a single regioisomer product
being generated in both cases (Scheme 2).
Mechanism and NIH shift
Isotopic labelling has been used extensively to study the cata-
lytic mechanisms of aromatic amino acid hydroxylases.[1, 4, 5, 22–24]
In this work, substrate deuterium labelling was employed to
probe the mechanism of Phe3H.[1, 25] [3,5-D2]-l-Phe was syn-
thesised in six steps from toluidine by enzymatic conversion of
[3,5-D2]phenylpyruvate to [3,5-D2]-l-phenylalanine as the final
step.[26,27] The final l-phenylalanine consisted of 90% D2, 10%
Table 1. Kinetic parameters for Phe3H for different substrates and co-
factors.
Substrate Cofactor KM
[a] kcat kcat/KM
[mm] [min@1][a] [mm@1 min@1]
1 l-Phe DMPH4 0.65:0.04 75:1 120:2.0
(0.098:0.01) (78:3) (800:39)
2 l-Phe 6MPH4 0.40:0.06 38:2 95:7.1
(0.039:0.002) (48:2) (1200:55)
(0.11:0.02)[c] (89:9)[c] (840:110)
3[b] l-Phe[b] 6MPH4
[b] 1.1:0.2 1.3:0.1 1.2:0.13
(0.026:0.004)[b] (1.2:0.04)[b] (46.16:2.6)
4 4F-dl-Phe 6MPH4 0.23:0.06 14:0.5 63:6.4
5 2F-dl-Phe 6MPH4 1.9:0.1 10:0.2 5.3:0.12
6 [3,5-D2]-l-
Phe
6MPH4 0.54:0.07 34:1 63:2.9
[a] Michaelis–Menten kinetic parameters for the amino acid substrate
with fixed pterin concentration; values for the pterin cofactor with fixed
l-Phe concentration are provided in brackets. [b] Kinetic parameters re-
ported by Zhang et al. [c] Michaelis–Menten parameters with substrate in-
hibition, Ki=0.5:0.1 mm. Reactions were carried out at 28 8C under the
optimised assay conditions and quenched after 3 min reaction time to
measure the initial rate.
Scheme 2. Regioselectivity of Phe3H-catalysed hydroxylation of l-Phe and l-Phe derivatives. Reactions were carried out at 28 8C for 3 h with 5 mm purified
Phe3H and 1 mm amino acid substrate in HEPES buffer containing catalase and superoxidase dismutase (SOD). Products were characterised by using LC-MS
and NMR spectroscopy.
ChemBioChem 2020, 21, 417 – 422 www.chembiochem.org T 2019 The Authors. Published by Wiley-VCH Verlag GmbH&Co. KGaA, Weinheim419
Full Papers
D1 and <1% D0 l-Phe as determined by integration of residual
5-H signal in the 1H NMR spectrum and the relative intensities
of isotope peaks in the mass spectrum. The steady-state
parameters for [3,5-D2]-l-Phe were slightly slower than those
of the nondeuterated Phe (Table 1, entry 6). To interrogate the
mechanism further, [3,5-D2]-l-Phe was incubated with Phe3H,
and the products were isolated and analysed by 1H and
2H NMR spectroscopy (Figure S17). From these experiments, it
was seen that the deuterium at the unreacted meta-position
C-3 (7.18 ppm) was completely retained, as shown by the rela-
tive intensity of the residual C-5@H signal. Aromatic amino acid
hydroxylases have been demonstrated to operate by a mecha-
nism that involves an NIH shift. In all previous mechanistic
studies (typically with Trp and Phe hydroxylases) the deuterium
or tritium label from the hydroxylation position was present in
>60% of the product.[1, 4, 22,24, 25] Unexpectedly, in this work with
Phe3H, the second deuterium atom was lost. The almost com-
plete loss of one deuterium from [3,5-D2]-l-phenylalanine that
we observe is therefore striking and suggests that a mecha-
nism different from the conventional NIH shift operates for
Phe3H.
Mutational analysis
There are three possible mechanisms that could account for
the loss of the deuterium label. A radical abstraction followed
by oxygen rebound, akin to a-ketoglutarate-dependent dioxy-
genases, would result in loss of the ipso-deuterium. Although a
radical mechanism has recently been proposed for the FeII-
dependent hydroxylase PqqB as a key step in the biosynthesis
of the cofactor pyrroloquinoline quinone (PQQ), this enzyme
does not use a pterin cofactor ; rather, dioxygen is directly
activated by the FeII centre.[28] To date, there is no evidence to
support a radical mechanism for iron- and pterin-dependent
hydroxylases.[1, 6, 29] Alternatively, electrophilic aromatic substitu-
tion of the ferryl-oxo species would yield the cationic inter-
mediate. In the presence of a suitably positioned basic residue,
the deuterium could be abstracted either in the ipso position
or in the ortho position after 1,2-hydride shift. If both the NIH
shift and proton abstraction are stereospecific, this could ac-
count for our observed loss of the deuterium label.
The third option is direct deprotonation following electro-
philic addition of the ferryl-oxo species. For this to occur, the
proton-acceptor residue would have to be positioned close to
the aromatic ring on the opposite side of the iron centre. C187
and T202 have previously been proposed as residues impor-
tant in conferring regioselectivity for this enzyme.[10] Walsh and
co-workers have previously reported the C187F mutant to be
inactive and the T202G variant and the T202G/C187F double
mutant to show a greater preference for hydroxylate at the
para position, with this preference being most notable for
the double mutant. It was proposed that both C187 and T202
act in concert to control the regiospecific hydroxylation of
l-Phe.[10]
Inspection of the alignment of Phe3H with the well-charac-
terised Phe4H and tyrosine 3-hydroxylase homologues (Fig-
ure S22) revealed that C187 substitutes for the Phe residue
found in Phe 4-hydroxylases, Tyr 3-hydroxylases and Trp 5-hy-
droxylases. This Phe residue, together with a strictly conserved
proline residue and a tryptophan residue (Phe in Trp hydroxy-
lases), provides hydrophobic and p-stacking interactions with
the aromatic substrate side chain. It is noteworthy that all phe-
nylalanine 3-hydroxylases (from the napsamycin, sansanmycin,
sanglifehrin pathways) contain Cys in the place of Phe. T202 of
Phe3H is also specific to Phe 3-hydroxylases and substitutes for
the Gly residue that is present in Phe 4-hydroxylases. T202 is
located close to the putative substrate binding site in homolo-
gy model studies (Figure S23).[10]
To probe the function of these residues, a panel of Phe3H
C187 and T202 mutants was generated, and the kinetics werer
measured with both l-Phe and [D2]-l-Phe (Table 2). Intriguingly,
C187A retained activity, albeit with lower kcat, and fourfold
lower KM. C187S was also active, however the reaction rate was
too slow to be determined by using Michaelis–Menten kinetics.
Both mutants exclusively formed the meta-Tyr isomer. The
T202S mutant, which was designed to retain chemical reactivi-
ty whilst altering the steric environment, lost regiospecificity,
with 20% of the para product being observed, and catalysed
the reaction at a much lower rate than the WT enzyme. Phe3H
T202A displayed very slow hydroxylase activity, to the extent
that it was not possible to measure the kinetic parameters.
After prolonged reaction time, however, it was observed that
both para- and meta-Tyr had been produced, with meta-tyro-
sine being produced at faster rate than para-Tyr (Figure S24)
giving an overall product distribution of 33% para- and 67%
meta- (Table 2).
Table 2. Regioselectivity and kinetic parameters of hydroxylation of l-Phe and [D2]Phe by Phe3H WT and Phe3H single-point mutants. Time-course experi-
ments indicated C187S and T202A to be over 45 times slower than T202S; as such, accurate determination of kcat and KM for these mutants was not possi-
ble.
Enzyme Regioselectivity kcat [min
@1] KM [mm]
l-Phe [D2]Phe l-Phe [D2]Phe
Phe3H 100% meta 38:2 34:1 0.40:0.06 0.54:0.07
Phe3H C187A 100% meta 17:0.3 13:0.4 0.1:0.01 0.13:0.03
Phe 3H C187S 100% meta n.d. n.d. n.d. n.d.
Phe3H T202S 80% meta
20% para
26:5 13:4 0.5:0.2 0.4:0.3
Phe3H T202A 33% para
67% meta
n.d. n.d. n.d. n.d.
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To gain a greater understanding of the process catalysed by
this mutant, the two regioisomeric products of the Phe3H
T202A-catalysed reaction were isolated and studied by NMR
spectroscopy. Intriguingly, for meta-Tyr, 80% of the product
retained both deuterium labels, either at the 3, 4- or 2, 5-posi-
tions, thus indicating that, for this mutant, the NIH shift mech-
anism must operate like that observed for Phe4Hs (Scheme 3).
In the case of para-Tyr, 63% of the product retained both deu-
terium labels. This much higher level of retention than seen for
the WT enzyme is again more consistent with the NIH-shift
mechanism that operates in Phe4Hs. It is noteworthy that, for
the other mutant (T202S), the meta-Tyr product obtained had
lost the second deuterium label.
These data provide strong evidence that T202 acts as a
switch between hydride shift (NIH mechanism) and direct
deprotonation or stereospecific NIH shift and deprotonation.
These two possible reactions of the cationic intermediate are
shown in Scheme 4. Evidence from the kinetic and labelling
studies in combination with the reduced efficiency of T202
mutants indicate that Thr-OH coordination in combination
with energetically favourable re-aromatisation through depro-
tonation mediates this important distinction in mechanism
compared to homologues such as the Phe4Hs bearing Gly
rather than Thr. It is clear that T202 also plays an important
role in directing the regiochemical outcome.
Conclusion
To conclude, Phe3H from S. coeruleorubidus has been demon-
strated to be an efficient enzyme for the production of meta-
tyrosine and to regiospecifically hydroxylate two fluorinated
substrate analogues. Contrary to the established mechanism
for phenylalanine para-hydroxylase, deuterium labelling experi-
ments showed that Phe3H from S. coeruleorubidus does not
necessarily operate through an NIH shift mechanism. Accord-
ing to our isotopic labelling studies, the loss of the ferryl-oxo
species might occur without C@H bond migration or otherwise
involves stereospecific NIH shift and deprotonation. Further-
more, investigation of the enzyme kinetics of T202A with l-Phe
and [D2]-l-Phe as the substrate revealed a significant isotope
effect, as well as a partial change in regioselectivity, thus indi-
cating that this residue plays an important role in the catalytic
mechanism of this enzyme.
This insight into the catalytic mechanism of this unique set
of enzymes could help to inform the design of biologically in-
spired catalysts for C@H bond functionalisation or rational en-
gineering of hydroxylases to widen their substrate scope and
synthetic utility.
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